Guidance

Tuberculosis (TB): Interferon Gamma Release Assay tests

The use of Interferon Gamma Release Assay (IGRA) testing for Tuberculosis (TB).

• From: Public Health England
• Published: 19 July 2013
• Last updated: 6 February 2025 — See all updates

This publication was withdrawn on 6 February 2025

This guidance is out of date and has been superseded by NICE guideline [NG33]: Tuberculosis](https://www.nice.org.uk/guidance/ng33)’.

Documents

[Withdrawn] Position statement on the use of Interferon Gamma Release Assay tests for Tuberculosis

PDF, 955 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document is a response to the 2011 guidance from the National Institute for Health and Care Excellence (NICE) on Interferon Gamma Release Assay tests.

Published 19 July 2013
Last updated 6 February 2025 + show all updates

1. 6 February 2025

   The guidance has been withdrawn.

2. 19 July 2013

   First published.